Virtual Medicinal Product (VMP)
-
Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials
Name Details
|
Current Name
Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials
|
Start Date
06-01-2022
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.5
- UDFS UOM
- ml
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- ATC Code
-
n/a
| BNF |
|
Current BNF
14040000
|
Start Date
01-02-2023
|
End Date
|
|
Previous BNF
14040000
|
Start Date
06-01-2022
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 40411511000001102 |
06-01-2022 |
|
Virtual Medicinal Product Pack (VMPP) Information